Previous Close | 239.67 |
Open | 239.72 |
Bid | 0.00 x 800 |
Ask | 248.99 x 800 |
Day's Range | 238.07 - 242.53 |
52 Week Range | 191.97 - 247.99 |
Volume | |
Avg. Volume | 591,835 |
Market Cap | 20.181B |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | 45.87 |
EPS (TTM) | 5.26 |
Earnings Date | Oct 24, 2024 |
Forward Dividend & Yield | 2.88 (1.19%) |
Ex-Dividend Date | Nov 26, 2024 |
1y Target Est | 261.06 |
Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SABCS) on December 13, 2024. SABCS is the preeminent conference for sharing cutting-edge breast cancer research with healthcare professionals, researchers, and
Labcorp Holdings Inc. ( NYSE:LH ) saw a decent share price growth of 13% on the NYSE over the last few months. The...